SCHEMBL3183117

SCHEMBL3183117

CCC(C(=O)NC(CC(=O)OC(C)(C)C)C(=O)CF)c1cccn(Cc2ccccc2C(C)(C)C)c1=O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.34
KDM4E B2RXH2 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
PTGER3 P43115 7/20 0.33
CASP3 P42574 4/20 0.32
NPSR1 Q6W5P4 1/20 0.32
LMNA P02545 2/20 0.32
TP53 P04637 2/20 0.32
RXFP1 Q9HBX9 2/20 0.32
SCN9A Q15858 2/20 0.31
CASP7 P55210 1/20 0.31
CASP9 P55211 1/20 0.31
CASP6 P55212 1/20 0.31
CASP8 Q14790 1/20 0.31
HDAC3 O15379 1/20 0.31
HDAC4 P56524 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC7 Q8WUI4 1/20 0.31
HDAC2 Q92769 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3175817 0.90 CASP3 (0.39) ALDH1A1KDM4EMEN1KMT2APTGER3
SCHEMBL3182350 0.88 KDM4E (0.39) ALDH1A1KDM4EMEN1KMT2APTGER3
SCHEMBL4253843 0.86 NPBWR1 (0.32) CASP3SCN9ACASP7CASP9CASP6
SCHEMBL13531566 0.83 ALDH1A1 (0.37) ALDH1A1KDM4EMEN1KMT2APTGER3
SCHEMBL3183997 0.82 KDM4E (0.38) ALDH1A1KDM4EMEN1KMT2APTGER3
SCHEMBL4255978 0.81 NPBWR1 (0.38) LMNASCN9A
SCHEMBL4253431 0.78 NPBWR1 (0.30)
SCHEMBL4253440 0.78 NPBWR1 (0.30)
SCHEMBL3181740 0.77 CASP3 (0.41) ALDH1A1KDM4EMEN1KMT2APTGER3
SCHEMBL4253900 0.77 LMNA (0.36) ALDH1A1MEN1KMT2APTGER3NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100016376-A1 CASPASE INHIBITORS BASED ON PYRIDONE SCAFFOLD LG LIFE SCIENCES LTD. (KR) 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100016376-A1 CASPASE INHIBITORS BASED ON PYRIDONE SCAFFOLD CASP1, CASP5, CASP2 ALDH1A1 3290/4885KDM4E 1345/4885MEN1 3320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.